Literature DB >> 21161728

Is silver nitrate pleurodesis for patients with malignant pleural effusion feasible and safe when performed in an outpatient setting?

Ricardo Mingarini Terra1, So Yeon Kim, Paulo Manuel Pego-Fernandes, Lisete Ribeiro Teixeira, Francisco Suso Vargas, Fabio Biscegli Jatene.   

Abstract

BACKGROUND: The purpose of this study was to analyze the effectiveness and safety of silver nitrate pleurodesis (SNP) in patients with recurrent malignant pleural effusion (RMPE) when performed in an outpatient setting.
MATERIALS AND METHODS: Prospective study including patients with RMPE recruited in a tertiary university-based hospital from February 2008 to June 2009. Elected patients underwent pleural catheter insertion (Day 1) followed by 0.5% SNP (Day 2), and on 7th day the drain was removed. All procedures were performed in an outpatient facility. Pleurodesis was considered successful when no additional pleural procedure was necessary by the 30th day. Complications were registered and graded according to the CTCAE3.0. Quality of life was evaluated before and 30 days after SNP.
RESULTS: A total of 68 patients (54 female, 14 male, mean age: 57.3 years) were included. In addition, 7 had bilateral pleural effusions; therefore, 75 hemithoraces were drained. Also, 5 were excluded, and 70 hemithoraces (63 patients) underwent SNP. During the period of 30 days postpleurodesis, 8 deaths not related to the procedure occurred, and we lost contact with 10 patients who were followed elsewhere. At the 30th day, 48 hemithoraces (45 patients) were reevaluated, and 2 recurrences observed. The most frequent complication was pain--graded as 3 or more in 7 patients; infection occurred in 2 patients. Physical and environmental aspects of quality of life improved significantly after pleurodesis.
CONCLUSIONS: In this study, SNP could be performed safely in an outpatient setting, with pain the most frequent complication. Recurrences occurred in 4% of the patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161728     DOI: 10.1245/s10434-010-1447-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.

Authors:  Ricardo Mingarini Terra; Leila Antonangelo; Alessandro Wasum Mariani; Ricardo Lopes Moraes de Oliveira; Lisete Ribeiro Teixeira; Paulo Manuel Pego-Fernandes
Journal:  Lung       Date:  2016-06-14       Impact factor: 2.584

Review 2.  Treatment of malignant pleural effusion.

Authors:  Ricardo Mingarini Terra; Alberto Jorge Monteiro Dela Vega
Journal:  J Vis Surg       Date:  2018-05-22

3.  The effect of silver nitrate pleurodesis after a failed thoracoscopic talc poudrage.

Authors:  Cecilia Menna; Claudio Andreetti; Mohsen Ibrahim; Giulio Maurizi; Camilla Poggi; Rocco Barile; Francesco Cassiano; Erino A Rendina
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

4.  Ultrasound-guided intrapleural positioning of pleural catheters: influence on immediate lung expansion and pleurodesis in patients with recurrent malignant pleural effusion.

Authors:  Pedro Henrique Xavier Nabuco de Araujo; Ricardo Mingarini Terra; Thiago da Silva Santos; Rodrigo Caruso Chate; Antonio Fernando Lins de Paiva; Paulo Manuel Pêgo-Fernandes
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

5.  Silver nitrate versus tetracycline in pleurodesis for malignant pleural effusions; a prospective randomized trial.

Authors:  Seyed Abass Tabatabaei; Seyed Mozafar Hashemi; Ali Kamali
Journal:  Adv Biomed Res       Date:  2015-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.